Sapyen, an Australian male fertility health technology company, has launched a laboratory-grade, at-home semen analysis tool.
The company’s Test Kit uses a patent-pending sperm stabilisation medium, SPX72. Sapyen has formulated a regulation-approved stabilisation solution that is claimed to extend sperm viability from 1 hour to up to three days, making it possible for men to ship samples to partner labs using existing postal infrastructure. This technology aims to ensure the sample remains at suitable quality as it travels from home via post to an accredited pathology clinic Australia wide.
A personalised report is shared within three days providing results and clear explanations on your next steps, including information for medical practitioners if further interventions are required.
The test is approved in multiple markets with successful FDA, TGA and CE registrations, and the laboratories Sapyen partner with are certified or accredited as per regional standards: NATA in Australia, CLIA in the US and HFEA in the UK.
Sapyen works with IVF clinics, fertility and vasectomy specialists, and healthcare practitioners across the US, UK and Europe, and Australia.
LipidPlan in a box ASCVD resources
LipidPlan in a box is intended to support GPs and primary care teams in undertaking QI activities...
MULTIGATE ProSeries Surgical Gowns
The MULTIGATE ProSeries surgical gown range has been designed to make gown selection simpler,...
ZEISS ARTEVO 800 digital microscope
The ZEISS ARTEVO 800 is an integrated digital microscope that allows for complete heads-up surgery.
